RHB Group Research analyst Shekhar Jaiswal has upgraded Raffles Medical to “buy” from “neutral” with a higher target price of $1.29 from 91 cents previously.

The upgrade comes amid anticipation that the private medical provider will return to business as usual.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply


Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook